Bing Zhao
-
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 3
- Drug Transport and Resistance Mechanisms 3
-
- Tuberculosis Research and Epidemiology 6
-
- Brain Metastases and Treatment 2
-
- Mycobacterium research and diagnosis 6
- Pneumocystis jirovecii pneumonia detection and treatment 2
-
- Multiple Myeloma Research and Treatments 2
- Journals
- SHILAP Revista de lepidopterología (1 paper)The Journal of Immunology (1 paper)Chemical Engineering Journal (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Bing Zhao
25 papers receiving 357 citations
Peers
Comparison fields: 5 of 76
- Oncology 168
- Infectious Diseases 49
- Molecular Biology 164
- Cancer Research 33
- Pulmonary and Respiratory Medicine 64
Countries citing papers authored by Bing Zhao
This map shows the geographic impact of Bing Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Zhao more than expected).
Fields of papers citing papers by Bing Zhao
This network shows the impact of papers produced by Bing Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Zhao. The network helps show where Bing Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bing Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 12 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 39 | |
| 10 | 2024 | 1 | |
| 11 | 2023 | 22 | |
| 12 | 2023 | 5 | |
| 13 | 2023 | 5 | |
| 14 | 2022 | 9 | |
| 15 | 2022 | 1 | |
| 16 | 2022 | 9 | |
| 17 | 2021 | 45 | |
| 18 | 2021 | 0 | |
| 19 | 2017 | 47 | |
| 20 | 2015 | 14 |
About Bing Zhao
Bing Zhao is a scholar working on Infectious Diseases, Oncology and Toxicology, having authored 29 papers that have together received 360 indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (6 papers), Tuberculosis Research and Epidemiology (6 papers), Cancer Treatment and Pharmacology (4 papers), HER2/EGFR in Cancer Research (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Multiple Myeloma Research and Treatments (2 papers), Brain Metastases and Treatment (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). The work is most often cited by research in Oncology (168 citations), Infectious Diseases (49 citations) and Molecular Biology (164 citations). Bing Zhao has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Jinbing Sun, Juan Ye, Peng Cao, Zhe‐Sheng Chen, Xinhui Zhang, Hong‐Min Liu, Liying Ma, Jun Li, Xuejiao Gao and Xi Chen. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Chemical Engineering Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.